{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:31:43Z","timestamp":1791538303801,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA068485"],"award-info":[{"award-number":["P30 CA068485"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["T32 HS026122"],"award-info":[{"award-number":["T32 HS026122"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00520-025-10136-1","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:40:28Z","timestamp":1763145628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inequities in supportive care medication use among older adults with metastatic pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"33","author":[{"given":"Alvina","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avirath U.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Besaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie B.","family":"Dusetzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley A.","family":"Jazowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"11","key":"10136_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"issue":"4","key":"10136_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT (2021) Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open 4(4):e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10136_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca Di Magliano M, Maitra A (2023) Pancreatic cancer: advances and challenges. Cell 186(8):1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014","journal-title":"Cell"},{"issue":"12","key":"10136_CR4","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.12998\/wjcc.v11.i12.2631","volume":"11","author":"K Michoglou","year":"2023","unstructured":"Michoglou K, Ravinthiranathan A, San Ti S, Dolly S, Thillai K (2023) Pancreatic cancer and depression. World J Clin Cases 11(12):2631\u20132636. https:\/\/doi.org\/10.12998\/wjcc.v11.i12.2631","journal-title":"World J Clin Cases"},{"issue":"1","key":"10136_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jjco\/hyv169","volume":"46","author":"N Akizuki","year":"2016","unstructured":"Akizuki N, Shimizu K, Asai M et al (2016) Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer: a longitudinal study. Jpn J Clin Oncol 46(1):71\u201377. https:\/\/doi.org\/10.1093\/jjco\/hyv169","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"10136_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102690","volume":"11","author":"R Mazur","year":"2023","unstructured":"Mazur R, Trna J (2023) Principles of palliative and supportive care in pancreatic cancer: a review. Biomedicines 11(10):2690. https:\/\/doi.org\/10.3390\/biomedicines11102690","journal-title":"Biomedicines"},{"issue":"3 Pt 2","key":"10136_CR7","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.lpm.2019.02.032","volume":"48","author":"AL V\u00e9die","year":"2019","unstructured":"V\u00e9die AL, Neuzillet C (2019) Pancreatic cancer: best supportive care. Presse Med Paris Fr 1983 48(3 Pt 2):e175\u2013e185. https:\/\/doi.org\/10.1016\/j.lpm.2019.02.032","journal-title":"Presse Med Paris Fr 1983"},{"issue":"12","key":"10136_CR8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1158\/1055-9965.EPI-23-0251","volume":"32","author":"JM Allen","year":"2023","unstructured":"Allen JM, Awunti M, Guo Y et al (2023) Unraveling racial disparities in supportive care medication use among end-of-life pancreatic cancer patients: focus on pain management and psychiatric therapies. Cancer Epidemiol Biomarkers Prev 32(12):1675\u20131682. https:\/\/doi.org\/10.1158\/1055-9965.EPI-23-0251","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10136_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MPA.0000000000002049","volume":"51","author":"A Landers","year":"2022","unstructured":"Landers A, Donaldson F, Brown H, McKenzie C, Pendharkar S (2022) The impact of pancreatic enzyme replacement therapy on patients with advanced pancreatic adenocarcinoma: a systematic review and narrative synthesis. Pancreas 51(5):405\u2013414. https:\/\/doi.org\/10.1097\/MPA.0000000000002049","journal-title":"Pancreas"},{"issue":"11","key":"10136_CR10","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/cam4.4610","volume":"11","author":"Z Lu","year":"2022","unstructured":"Lu Z, Zhang N, Giordano SH, Zhao H (2022) Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015. Cancer Med 11(11):2296\u20132307. https:\/\/doi.org\/10.1002\/cam4.4610","journal-title":"Cancer Med"},{"issue":"1","key":"10136_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1089\/heq.2019.0057","volume":"3","author":"M Noel","year":"2019","unstructured":"Noel M, Fiscella K (2019) Disparities in pancreatic cancer treatment and outcomes. Health equity 3(1):532\u2013540. https:\/\/doi.org\/10.1089\/heq.2019.0057","journal-title":"Health equity"},{"issue":"1","key":"10136_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jamcollsurg.2011.09.022","volume":"214","author":"SC Mayo","year":"2012","unstructured":"Mayo SC, Gilson MM, Herman JM et al (2012) Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg 214(1):33\u201345. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2011.09.022","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10136_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MLR.0000000000001216","volume":"58","author":"OF Jarr\u00edn","year":"2020","unstructured":"Jarr\u00edn OF, Nyandege AN, Grafova IB, Dong X, Lin H (2020) Validity of race and ethnicity codes in Medicare administrative data compared to gold-standard self-reported race collected during routine home health care visits. Med Care 58(1):e1\u2013e8. https:\/\/doi.org\/10.1097\/MLR.0000000000001216","journal-title":"Med Care"},{"issue":"7","key":"10136_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702\u2013706. https:\/\/doi.org\/10.1093\/aje\/kwh090","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10136_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/j.1475-6773.2006.00583.x","volume":"41","author":"TG McGuire","year":"2006","unstructured":"McGuire TG, Alegria M, Cook BL, Wells KB, Zaslavsky AM (2006) Implementing the institute of medicine definition of disparities: an application to mental health care. Health Serv Res 41(5):1979\u20132005. https:\/\/doi.org\/10.1111\/j.1475-6773.2006.00583.x","journal-title":"Health Serv Res"},{"issue":"3","key":"10136_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1475-6773.2010.01100.x","volume":"45","author":"B L\u00ea Cook","year":"2010","unstructured":"L\u00ea Cook B, McGuire TG, Lock K, Zaslavsky AM (2010) Comparing methods of racial and ethnic disparities measurement across different settings of mental health care. Health Serv Res 45(3):825\u2013847. https:\/\/doi.org\/10.1111\/j.1475-6773.2010.01100.x","journal-title":"Health Serv Res"},{"issue":"8","key":"10136_CR17","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s00520-016-3174-6","volume":"24","author":"DK Check","year":"2016","unstructured":"Check DK, Rosenstein DL, Dusetzina SB (2016) Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer. Support Care Cancer 24(8):3463\u20133472. https:\/\/doi.org\/10.1007\/s00520-016-3174-6","journal-title":"Support Care Cancer"},{"issue":"1","key":"10136_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/jgs.12063","volume":"61","author":"DE Jimenez","year":"2013","unstructured":"Jimenez DE, Cook B, Bartels SJ, Alegr\u00eda M (2013) Disparities in mental health service use of racial and ethnic minority elderly adults. J Am Geriatr Soc 61(1):18\u201325. https:\/\/doi.org\/10.1111\/jgs.12063","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10136_CR19","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jagp.2022.07.001","volume":"30","author":"DE Jimenez","year":"2022","unstructured":"Jimenez DE, Park M, Rosen D et al (2022) Centering culture in mental health: differences in diagnosis, treatment, and access to care among older people of color. Am J Geriatr Psychiatry 30(11):1234\u20131251. https:\/\/doi.org\/10.1016\/j.jagp.2022.07.001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10136_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.1466","author":"JE Berchuck","year":"2020","unstructured":"Berchuck JE, Meyer CS, Zhang N et al (2020) Association of mental health treatment with outcomes for US veterans diagnosed with non-small cell lung cancer. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1466","journal-title":"JAMA Oncol"},{"issue":"10","key":"10136_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257794","volume":"16","author":"K Fiscella","year":"2021","unstructured":"Fiscella K, Epstein RM, Griggs JJ, Marshall MM, Shields CG (2021) Is physician implicit bias associated with differences in care by patient race for metastatic cancer-related pain? PLoS One 16(10):e0257794. https:\/\/doi.org\/10.1371\/journal.pone.0257794","journal-title":"PLoS One"},{"key":"10136_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000003243","author":"LM Hickling","year":"2024","unstructured":"Hickling LM, Allani S, Cella M, Scott W (2024) A systematic review with meta-analyses of the association between stigma and chronic pain outcomes. Pain. https:\/\/doi.org\/10.1097\/j.pain.0000000000003243","journal-title":"Pain"},{"issue":"10","key":"10136_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jpain.2022.05.006","volume":"23","author":"DJ Bean","year":"2022","unstructured":"Bean DJ, Dryland A, Rashid U, Tuck NL (2022) The determinants and effects of chronic pain stigma: a mixed methods study and the development of a model. J Pain 23(10):1749\u20131764. https:\/\/doi.org\/10.1016\/j.jpain.2022.05.006","journal-title":"J Pain"},{"issue":"2","key":"10136_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11606-017-4199-3","volume":"33","author":"EL McQuaid","year":"2018","unstructured":"McQuaid EL, Landier W (2018) Cultural issues in medication adherence: disparities and directions. J Gen Intern Med 33(2):200\u2013206. https:\/\/doi.org\/10.1007\/s11606-017-4199-3","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10136_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1370\/afm.2632","volume":"19","author":"M Bazargan","year":"2021","unstructured":"Bazargan M, Cobb S, Assari S (2021) Discrimination and medical mistrust in a racially and ethnically diverse sample of California adults. Ann Fam Med 19(1):4\u201315. https:\/\/doi.org\/10.1370\/afm.2632","journal-title":"Ann Fam Med"},{"issue":"14","key":"10136_CR26","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1200\/JCO.22.01413","volume":"41","author":"AC Enzinger","year":"2023","unstructured":"Enzinger AC, Ghosh K, Keating NL et al (2023) Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of life. J Clin Oncol 41(14):2511\u20132522. https:\/\/doi.org\/10.1200\/JCO.22.01413","journal-title":"J Clin Oncol"},{"issue":"10","key":"10136_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/pon.4218","volume":"25","author":"KD Stein","year":"2016","unstructured":"Stein KD, Alcaraz KI, Kamson C, Fallon EA, Smith TG (2016) Sociodemographic inequalities in barriers to cancer pain management: a report from the American Cancer Society\u2019s study of cancer survivors-II (SCS-II). Psychooncology 25(10):1212\u20131221. https:\/\/doi.org\/10.1002\/pon.4218","journal-title":"Psychooncology"},{"issue":"1","key":"10136_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/pam.22259","volume":"40","author":"M McInerney","year":"2021","unstructured":"McInerney M, Mellor JM, Sabik LM (2021) Welcome mats and on-ramps for older adults: the impact of the Affordable Care Act\u2019s Medicaid expansions on dual enrollment in Medicare and Medicaid. J Policy Anal Manage 40(1):12\u201341. https:\/\/doi.org\/10.1002\/pam.22259","journal-title":"J Policy Anal Manage"},{"issue":"5","key":"10136_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/1475-6773.14155","volume":"58","author":"JM Mellor","year":"2023","unstructured":"Mellor JM, McInerney M, Garrow RC, Sabik LM (2023) The impact of Medicaid expansion on spending and utilization by older low-income Medicare beneficiaries. Health Serv Res 58(5):1024\u20131034. https:\/\/doi.org\/10.1111\/1475-6773.14155","journal-title":"Health Serv Res"},{"issue":"3","key":"10136_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1257\/pol.20150402","volume":"9","author":"M McInerney","year":"2017","unstructured":"McInerney M, Mellor JM, Sabik LM (2017) The effects of state Medicaid expansions for working-age adults on senior Medicare beneficiaries. Am Econ J Econ Policy 9(3):408\u2013438","journal-title":"Am Econ J Econ Policy"},{"issue":"6","key":"10136_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxae059","volume":"2","author":"R Sachs","year":"2024","unstructured":"Sachs R, Duchovny N, Varcie J, White C (2024) Among Medicare beneficiaries, Affordable Care Act coverage expansions reduced utilization of ambulatory care, particularly among duals. Health Aff Sch 2(6):qxae059. https:\/\/doi.org\/10.1093\/haschl\/qxae059","journal-title":"Health Aff Sch"},{"issue":"6","key":"10136_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1373","volume":"3","author":"M McInerney","year":"2022","unstructured":"McInerney M, McCormack G, Mellor JM, Sabik LM (2022) Association of Medicaid expansion with Medicaid enrollment and health care use among older adults with low income and chronic condition limitations. JAMA Health Forum 3(6):e221373. https:\/\/doi.org\/10.1001\/jamahealthforum.2022.1373","journal-title":"JAMA Health Forum"},{"issue":"5","key":"10136_CR33","first-page":"121","volume":"20","author":"GT Brennan","year":"2019","unstructured":"Brennan GT, Saif MW (2019) Pancreatic enzyme replacement therapy: a concise review. JOP J Pancreas 20(5):121\u2013125","journal-title":"JOP J Pancreas"},{"issue":"3","key":"10136_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MPA.0000000000000767","volume":"46","author":"T Saito","year":"2017","unstructured":"Saito T, Hirano K, Isayama H et al (2017) The role of pancreatic enzyme replacement therapy in unresectable pancreatic cancer: a prospective cohort study. Pancreas 46(3):341\u2013346. https:\/\/doi.org\/10.1097\/MPA.0000000000000767","journal-title":"Pancreas"},{"issue":"4","key":"10136_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041331","volume":"15","author":"X Lan","year":"2023","unstructured":"Lan X, Robin G, Kasnik J, Wong G, Abdel-Rahman O (2023) Challenges in diagnosis and treatment of pancreatic exocrine insufficiency among patients with pancreatic ductal adenocarcinoma. Cancers (Basel) 15(4):1331. https:\/\/doi.org\/10.3390\/cancers15041331","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10136_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.pan.2021.05.002","volume":"21","author":"A Gupta","year":"2021","unstructured":"Gupta A, Premnath N, Sedhom R et al (2021) Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D. Pancreatology 21(5):1009\u20131010. https:\/\/doi.org\/10.1016\/j.pan.2021.05.002","journal-title":"Pancreatology"},{"issue":"5","key":"10136_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1200\/JCO.2017.74.5091","volume":"36","author":"JA Doshi","year":"2018","unstructured":"Doshi JA, Li P, Huo H, Pettit AR, Armstrong KA (2018) Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents. J Clin Oncol 36(5):476\u2013482. https:\/\/doi.org\/10.1200\/JCO.2017.74.5091","journal-title":"J Clin Oncol"},{"key":"10136_CR38","unstructured":"The costs of cancer in the Black community. American Cancer Society Cancer Action Network. October 19, 2022. Accessed September 22, 2024. https:\/\/www.fightcancer.org\/policy-resources\/costs-cancer-black-community-0"},{"key":"10136_CR39","unstructured":"The costs of cancer in people of color. American Cancer Society Cancer Action Network. 2023. Accessed September 22, 2024. https:\/\/www.facs.org\/media\/gf4jq4ad\/costs-of-cancer-in-people-of-color.pdf"},{"issue":"5","key":"10136_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.37765\/ajmn.2023.89357","volume":"29","author":"SA Jazowski","year":"2023","unstructured":"Jazowski SA, Samuel-Ryals CA, Wood WA, Zullig LL, Trogdon JG, Dusetzina SB (2023) Association between low-income subsidies and inequities in orally administered antimyeloma therapy use. Am J Manag Care 29(5):246\u2013254. https:\/\/doi.org\/10.37765\/ajmn.2023.89357","journal-title":"Am J Manag Care"},{"issue":"1","key":"10136_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2022.11.003","volume":"41","author":"I Abuali","year":"2023","unstructured":"Abuali I, Patel S, Kiel L, Meza K, Florez N (2023) Disparities in cancer care\u2014a call to action. Cancer Cell 41(1):1\u20134. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.003","journal-title":"Cancer Cell"},{"issue":"3","key":"10136_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.18553\/jmcp.2016.22.3.227","volume":"22","author":"BS Seal","year":"2016","unstructured":"Seal BS, Anderson S, Shermock KM (2016) Factors associated with adherence rates for oral and intravenous anticancer therapy in commercially insured patients with metastatic colon cancer. J Manag Care Spec Pharm 22(3):227\u2013235. https:\/\/doi.org\/10.18553\/jmcp.2016.22.3.227","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"10136_CR43","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/j.pec.2011.07.015","volume":"85","author":"RLJ Thornton","year":"2011","unstructured":"Thornton RLJ, Powe NR, Roter D, Cooper LA (2011) Patient-physician social concordance, medical visit communication and patients\u2019 perceptions of health care quality. Patient Educ Couns 85(3):e201-208. https:\/\/doi.org\/10.1016\/j.pec.2011.07.015","journal-title":"Patient Educ Couns"},{"issue":"5","key":"10136_CR44","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1377\/hlthaff.2020.01699","volume":"40","author":"JS Guadamuz","year":"2021","unstructured":"Guadamuz JS, Wilder JR, Mouslim MC, Zenk SN, Alexander GC, Qato DM (2021) Fewer pharmacies in Black and Hispanic\/Latino neighborhoods compared with White or diverse neighborhoods, 2007\u201315. Health Aff Millwood 40(5):802\u2013811. https:\/\/doi.org\/10.1377\/hlthaff.2020.01699","journal-title":"Health Aff Millwood"},{"issue":"1","key":"10136_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JOP.2013.001319","volume":"10","author":"W Yang","year":"2014","unstructured":"Yang W, Williams JH, Hogan PF et al (2014) Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage. J Oncol Pract 10(1):39\u201345. https:\/\/doi.org\/10.1200\/JOP.2013.001319","journal-title":"J Oncol Pract"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10136-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10136-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10136-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:31:39Z","timestamp":1765949499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10136-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10136"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10136-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This observational study was conducted in accordance with the principles of the Declaration of Helsinki and was deemed exempt by the Institutional Review Board at Vanderbilt University Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Ms. Liang, Messrs. Vaidya and Besaw, and Drs. Gupta and Jazowski report no conflicts of interest. Dr. Dusetzina reports funding from Arnold Ventures, the Commonwealth Fund, and the Leukemia & Lymphoma Society, and is a member of the Institute for Clinical and Economic Review\u2019s (ICER) Midwestern Comparative Effectiveness Advisory Council and a member of the Medicare Payment Advisory Commission (MedPAC). This work does not necessarily represent the official position of ICER or MedPAC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The sponsor of this study was not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder"}}],"article-number":"1063"}}